Cambridge, Massachusetts, United States
Contact Info
562 followers
500+ connections
Activity
-
Good bye the CD56dim and CD56bright NK cell nomenclature. NK cells come in 3 flavors: NK1, NK2 and NK3. We are thrilled to announce the publication…
Good bye the CD56dim and CD56bright NK cell nomenclature. NK cells come in 3 flavors: NK1, NK2 and NK3. We are thrilled to announce the publication…
Liked by Gabrielle Wong
-
Very pleased our latest paper is finally out, attempting to address why OX40 antibodies haven't penetrated clinically. Great collaboration with GSK…
Very pleased our latest paper is finally out, attempting to address why OX40 antibodies haven't penetrated clinically. Great collaboration with GSK…
Liked by Gabrielle Wong
-
Congratulations to the 2023-24 Northwest Women's Leadership Cohort graduates! A special shout out to Grace Wong, Assistant City Attorney for the City…
Congratulations to the 2023-24 Northwest Women's Leadership Cohort graduates! A special shout out to Grace Wong, Assistant City Attorney for the City…
Liked by Gabrielle Wong
Experience & Education
Publications
-
Optical imaging of fluorescent periostin enables early endosopic detection of esophageal squamous cell carcinoma in mice
Gastroenterology
We describe a novel imaging strategy that detects early stage esophageal squamous cell carcinoma (ESCC) when combined with endoscopic approaches that could help improve clinical outcomes. We had previously identified Periostin as an integrin-binding protein that is important in the tumor microenvironment. We created a fluorescent-labeled antibody that recognizes periostin and binds specifically to ESCC xenograft tumors in mice. In L2-cre;p120ctnLoxP/LoxP mice, which develop squamous cell…
We describe a novel imaging strategy that detects early stage esophageal squamous cell carcinoma (ESCC) when combined with endoscopic approaches that could help improve clinical outcomes. We had previously identified Periostin as an integrin-binding protein that is important in the tumor microenvironment. We created a fluorescent-labeled antibody that recognizes periostin and binds specifically to ESCC xenograft tumors in mice. In L2-cre;p120ctnLoxP/LoxP mice, which develop squamous cell cancers that resemble human ESCC, we visualized the probe in preneoplastic and neoplastic esophageal lesions using near-infrared fluorescent imaging with upper-gastrointestinal endoscopy. Periostin might be a biomarker of the esophageal tumor microenvironment that can be used to detect preneoplastic lesions.
Other authors -
-
Matricellular proteins: Priming the tumor microenvironment for cancer development and metastasis
British Journal of Cancer
Mini review of matricellular proteins and theirr roles in promoting tumor growth and metastasis through facilitating protein-protein interactions within the tumor microenvironment
Other authors -
-
Periostin cooperates with mutant p53 to mediate invasion through induction of STAT1 signaling in the tumor microenvironment
Oncogenesis
We had previously described that matricellular protein, periostin (POSTN) as important for invasion in ESCC tumor microenvironment. In this study, we observe that the inducible knockdown of POSTN decreases esophageal squamous cell carcinoma (ESCC) tumor growth in vivo and demonstrate that POSTN cooperates with a conformational missense p53 mutation to enhance invasion. Pathway analyses reveal that invasive esophageal cells expressing POSTN and p53(R175H) mutation display activation of signal…
We had previously described that matricellular protein, periostin (POSTN) as important for invasion in ESCC tumor microenvironment. In this study, we observe that the inducible knockdown of POSTN decreases esophageal squamous cell carcinoma (ESCC) tumor growth in vivo and demonstrate that POSTN cooperates with a conformational missense p53 mutation to enhance invasion. Pathway analyses reveal that invasive esophageal cells expressing POSTN and p53(R175H) mutation display activation of signal transducer and activator of transcription 1 (STAT1) target genes, suggesting that the induction of STAT1 and STAT1-related genes could foster a permissive microenvironment that facilitates invasion of esophageal epithelial cells into the extracellular matrix. Furthermore, we find that STAT1 is activated in ESCC xenograft tumors, but this activation is attenuated with inducible knockdown of POSTN in ESCC tumors. Overall, these results highlight the novel molecular mechanisms supporting the capacity of POSTN in mediating tumor invasion during ESCC development and have implications of therapeutic strategies targeting the tumor microenvironment.
Other authors -
-
Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer
Cancer Research
We report that periostin, a highly expressed cell adhesion molecule, is a key component of a novel tumor-invasive signature obtained from an organotypic culture model of engineeredesophageal squamous cell carcinoma (ESCC). This tumor-invasive signature classifies with human ESCC microarrays, and genetic modulation of periostin promotes tumor cell migration and invasion as revealed in gain-of-loss and loss-of-function experiments. Inhibition of epidermal growth factor receptor signaling and…
We report that periostin, a highly expressed cell adhesion molecule, is a key component of a novel tumor-invasive signature obtained from an organotypic culture model of engineeredesophageal squamous cell carcinoma (ESCC). This tumor-invasive signature classifies with human ESCC microarrays, and genetic modulation of periostin promotes tumor cell migration and invasion as revealed in gain-of-loss and loss-of-function experiments. Inhibition of epidermal growth factor receptor signaling and restoration of wild-type p53 function were each found to attenuate periostin, suggesting the interdependence of two common genetic alterations with periostin function. Collectively, we demostrate periostin as an important mediator of ESCC tumor invasion and indicate that organotypic (three-dimensional) culture can offer an important tool to discover novel biological effectors in cancer.
Other authors -
More activity by Gabrielle
-
The FDA has granted lixudebart (ALE.F02) Orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). Great job done by the Team…
The FDA has granted lixudebart (ALE.F02) Orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). Great job done by the Team…
Liked by Gabrielle Wong
-
ASCO#2024 Our posters were a success, as crowds kept coming to see our exciting data on both our posters!
ASCO#2024 Our posters were a success, as crowds kept coming to see our exciting data on both our posters!
Liked by Gabrielle Wong
-
There was amazing buzz around our two posters at #ASCO2024! Our team enjoyed the exciting discussions around the results of our two Ph1 clinical…
There was amazing buzz around our two posters at #ASCO2024! Our team enjoyed the exciting discussions around the results of our two Ph1 clinical…
Liked by Gabrielle Wong
-
It is wonderful to be back in Chicago for #ASCO24. I am thrilled to see people gathering around our posters, discussing the results of our clinical…
It is wonderful to be back in Chicago for #ASCO24. I am thrilled to see people gathering around our posters, discussing the results of our clinical…
Liked by Gabrielle Wong
-
We are excited to share our initial HFB200301 and HFB301001 clinical data with you at #ASCO2024
We are excited to share our initial HFB200301 and HFB301001 clinical data with you at #ASCO2024
Liked by Gabrielle Wong
-
Meet us at The Citizens JMP Life Sciences Conference on Monday, May 13th at 1:30pm ET! Robert Andtbacka, MD, CM, FACS, FRCSC will host a company…
Meet us at The Citizens JMP Life Sciences Conference on Monday, May 13th at 1:30pm ET! Robert Andtbacka, MD, CM, FACS, FRCSC will host a company…
Liked by Gabrielle Wong
-
I’m thrilled to share the launch today of Delphia Therapeutics, a targeted oncology company focused on a paradigm-shifting approach:…
I’m thrilled to share the launch today of Delphia Therapeutics, a targeted oncology company focused on a paradigm-shifting approach:…
Liked by Gabrielle Wong
-
I am thrilled to share that I have joined Alentis Therapeutics as the Head of Translational Medicine. I am truly impressed with the depth and quality…
I am thrilled to share that I have joined Alentis Therapeutics as the Head of Translational Medicine. I am truly impressed with the depth and quality…
Liked by Gabrielle Wong
-
20 years. Wow. One could say, I like it here at Goodwin. I have enjoyed amazing growth, some truly awesome friendships, and technology that has blown…
20 years. Wow. One could say, I like it here at Goodwin. I have enjoyed amazing growth, some truly awesome friendships, and technology that has blown…
Liked by Gabrielle Wong
-
I am extremely thankful for this recognition. I could not have gotten this far without the delication and relentless drive of our amazing HiFiBiO…
I am extremely thankful for this recognition. I could not have gotten this far without the delication and relentless drive of our amazing HiFiBiO…
Liked by Gabrielle Wong
People also viewed
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Gabrielle Wong in United States
-
Gabrielle Wong
Recruitment Operations Manager at Maxim Healthcare Services
-
Gabrielle Wong
B.S. in Chemical & Biomolecular Engineering Georgia Tech Graduate | James A. Clark Scholar
-
Gabrielle Wong
Director, Americas Studio Projects & MAC at Morgan Stanley
-
Gabrielle (Gabby) Wong
18 others named Gabrielle Wong in United States are on LinkedIn
See others named Gabrielle Wong